Quantinuum (NASDAQ:QNT) Trading Up 11.5% – Time to Buy?

Quantinuum Inc. (NASDAQ:QNT)’s share price was up 11.5% on Wednesday . The company traded as high as $62.74 and last traded at $62.49. 618,515 shares changed hands during trading, a decline of 76% from the average session volume of 2,620,271 shares. The stock had previously closed at $56.06.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Oracle partnership supports commercial adoption. Quantinuum is deploying its 98-qubit Helios quantum computer in Oracle’s AI data centers and plans to make the system available through Oracle Cloud. The arrangement provides a high-profile customer and potential distribution channel for Quantinuum’s technology. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Positive Sentiment: Bookings and revenue growth attracted investor support. Analysts highlighted strong bookings, while coverage characterized the quarterly revenue performance as a beat. Commercial adoption, new partnerships and expected revenue growth are cited as potential drivers of substantial long-term upside. Quantinuum leaps after Q2 report; analysts highlight strong bookings
• Positive Sentiment: Analysts remain bullish. Rosenblatt reaffirmed a Buy rating with a $155 price target, while Needham maintained Buy with a $100 target and Cantor Fitzgerald reiterated Overweight with a $90 target. These targets reflect analysts’ confidence in Quantinuum’s long-term quantum-computing opportunity. Analyst rating coverage
• Neutral Sentiment: Q2 was Quantinuum’s first earnings report as a public company. Investors are establishing benchmarks for its revenue, bookings, spending and commercialization progress, increasing the potential for volatility around results and announcements. Quantinuum Q2 Earnings Snapshot
• Negative Sentiment: Profitability remains a concern. Quantinuum reported an adjusted loss of $0.28 per share, wider than the $0.26 consensus estimate, despite quarterly revenue of $8 million. Analysts expect a full-year loss, so investors may be taking profits while awaiting evidence that bookings and Oracle-related deployments can translate into sustained revenue and narrower losses. Quantinuum Q2 2026 earnings: revenue beats, losses widen

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on QNT shares. UBS Group assumed coverage on Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating and a $93.00 price objective for the company. JPMorgan Chase & Co. assumed coverage on Quantinuum in a research note on Monday, June 29th. They issued an “overweight” rating and a $97.00 price target on the stock. Mizuho began coverage on shares of Quantinuum in a research note on Monday, June 29th. They set an “outperform” rating and a $90.00 price objective for the company. Wall Street Zen lowered shares of Quantinuum from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Finally, Evercore started coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued an “outperform” rating and a $98.00 target price on the stock. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $98.42.

Quantinuum Stock Down 4.5%

The firm has a fifty day moving average price of $63.05.

Quantinuum (NASDAQ:QNT) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The company had revenue of $8.00 million for the quarter. Analysts expect that Quantinuum Inc. will post -1.61 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Hal Barron purchased 250,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, for a total transaction of $15,000,000.00. Following the acquisition, the director owned 255,833 shares in the company, valued at approximately $15,349,980. This trade represents a 4,285.96% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Manish H. Bhatia acquired 20,000 shares of the business’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $60.00 per share, for a total transaction of $1,200,000.00. Following the completion of the transaction, the director directly owned 25,833 shares of the company’s stock, valued at $1,549,980. This trade represents a 342.88% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have bought 411,032 shares of company stock worth $24,661,920.

Institutional Investors Weigh In On Quantinuum

An institutional investor recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC bought a new stake in shares of Quantinuum Inc. (NASDAQ:QNT) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 5,005 shares of the company’s stock, valued at approximately $409,000.

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.